As mentioned above, genomic studies from the TCGA and other groups have observed a similar prevalence of mutations in tumor suppressor genes APC and TP53 and in oncogenes KRAS and PIK3CA in older and younger colorectal cancer patients [30,31,32]. This evidence concerns the gene KRAS and colorectal cancer.